...
首页> 外文期刊>Biomacromolecules >Binding of Glyco-Acridine Derivatives to Lysozyme Leads to Inhibition of Amyloid Fibrillization
【24h】

Binding of Glyco-Acridine Derivatives to Lysozyme Leads to Inhibition of Amyloid Fibrillization

机译:糖A啶衍生物与溶菌酶的结合导致抑制淀粉样蛋白原纤维化。

获取原文
获取原文并翻译 | 示例

摘要

While amyloid-related diseases are at the center of intense research efforts, no feasible cure is currently available for these diseases. The experimental and computational techniques were used to study the ability of glyco-acridines to prevent lysozyme amyloid fibrillization in vitro. Fluorescence spectroscopy and atomic force microscopy have shown that glyco-acridines inhibit amyloid aggregation of lysozyme; the inhibition efficiency characterized by the half-maximal inhibition concentration IC_(50) was affected by the structure and concentration of the derivative. We next investigated relationship between the binding affinity and the inhibitory activity of the compounds. The semiempirical quantum PM6-DH+ method provided a good correlation pointing to the importance of quantum effects on the binding of glyco-acridine derivatives to lysozyme. The contribution of linkers may be explained by the valence bond theory. Our data provide a basis for the development of new small molecule inhibitors effective in therapy of amyloid-related diseases.
机译:尽管淀粉样蛋白相关疾病是大量研究工作的中心,但目前尚无针对这些疾病的可行治疗方法。实验和计算技术用于研究糖-啶在体外预防溶菌酶淀粉样蛋白原纤维化的能力。荧光光谱和原子力显微镜显示糖glyco啶可抑制溶菌酶的淀粉样聚集。以半数最大抑制浓度IC_(50)为特征的抑制效率受衍生物的结构和浓度影响。接下来,我们研究了化合物的结合亲和力和抑制活性之间的关系。半经验量子PM6-DH +方法提供了良好的相关性,指出了量子效应对糖-啶衍生物与溶菌酶结合的重要性。连接子的贡献可以通过价键理论来解释。我们的数据为开发有效治疗淀粉样蛋白相关疾病的新型小分子抑制剂提供了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号